Stocklytics Platform
RXL
ProShares Ultra Health Care
RXL
$110.12arrow_drop_down1.88%-$2.11

Performance History

Chart placeholder
Key Stats
Open$113.84
Prev. Close$113.33
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap-
PE Ratio-
LOWHIGH
Day Range112.58
113.84
52 Week Range74.44
117.47
Ratios
P/B Ratio-
Revenue-
Operating M. %-
Earnings-
Earnings Growth %-
EBITDA Margin %-
ROE %-
EPS-

About ProShares Ultra Health Care (RXL)

ProShares Ultra Health Care (RXL) is an exchange-traded fund (ETF) that seeks to provide double the daily performance of the Dow Jones U.S. Health Care Index. This ETF is designed for investors who want to amplify their exposure to the health care sector. With RXL, investors can get potentially enhanced returns but should also be aware of the increased risk and volatility associated with leveraged ETFs. The fund mainly consists of large-cap pharmaceutical, biotechnology, and health care equipment companies, providing investors with broad exposure to the health care industry.
As of the latest available data, the price history of ProShares Ultra Health Care, RXL shows significant fluctuations due to its daily leveraged performance. It is important for investors to consider their investment objectives and risk tolerance before investing in this ETF. The fund's price can be impacted by various factors, including the overall performance of the health care sector, regulatory changes, and individual company-specific news. Therefore, it is crucial to keep track of the latest news and developments in the health care industry when investing in RXL.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NYSE

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

add ProShares Ultra Health Care to watchlist

Keep an eye on ProShares Ultra Health Care

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media